Allison Meisner

1.3k total citations
34 papers, 875 citations indexed

About

Allison Meisner is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Allison Meisner has authored 34 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Allison Meisner's work include Prostate Cancer Treatment and Research (5 papers), Statistical Methods in Clinical Trials (4 papers) and Acute Kidney Injury Research (4 papers). Allison Meisner is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Statistical Methods in Clinical Trials (4 papers) and Acute Kidney Injury Research (4 papers). Allison Meisner collaborates with scholars based in United States, Canada and Sweden. Allison Meisner's co-authors include Michael Pencina, Joseph F. Polak, Ralph B. D’Agostino, Philip A. Wolf, Chirag R. Parikh, Kathleen F. Kerr, Maurizio Fava, Karol M. Pencina, Lisa Brown and Michelangelo Fiorentino and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Allison Meisner

33 papers receiving 851 citations

Peers

Countries citing papers authored by Allison Meisner

Since Specialization

Citations

This map shows the geographic impact of Allison Meisner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison Meisner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison Meisner more than expected).

Fields of papers citing papers by Allison Meisner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison Meisner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison Meisner. The network helps show where Allison Meisner may publish in the future.

Co-authorship network of co-authors of Allison Meisner

This figure shows the co-authorship network connecting the top 25 collaborators of Allison Meisner. A scholar is included among the top collaborators of Allison Meisner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison Meisner. Allison Meisner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrating oral pre-exposure prophylaxis delivery in primary care family planning clinics: a pragmatic, stepped-wedge, cluster-randomised trial 2025 ·Kenneth K. Mugwanya, Daniel Matemo, Allison Meisner, Torin Schaafsma, Jennifer F. Morton, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kristin Beima‐Sofie, Jared M. Baeten, John Kinuthia	0
2	Breastfeeding attributable fraction of triple negative breast cancer in the US 2025 ·npj Breast Cancer ·(unknown), (unknown), (unknown), Leah M. Ferrucci, Daniel F. Sarpong, Rafael Pérez‐Escamilla, Jessica B. Lewis, Amanda I. Phipps, Allison Meisner, Lajos Pusztai	1
3	Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor–Positive, Node-Positive Breast Cancer 2024 ·Journal of Clinical Oncology ·Lajos Pusztai, (unknown), Kathy S. Albain, William E. Barlow, Salomon M. Stemmer, Allison Meisner, Gabriel N. Hortobágyi, Steven Shak, James M. Rae, Frederick L. Baehner, Priyanka Sharma, Kevin Kalinsky	1
4	Adaptive HIV pre-exposure prophylaxis adherence interventions for young women in Johannesburg, South Africa: a sequential multiple-assignment randomised trial 2024 ·The Lancet HIV ·Jennifer Velloza, (unknown), Allison Meisner, (unknown), (unknown), Cole Grabow, (unknown), (unknown), (unknown), Deborah Donnell, Jared M. Baeten, Sybil Hosek, Connie Celum, Sinead Delany‐Moretlwe	5
5	Integrating PrEP delivery in public health family planning clinics: a protocol for a pragmatic stepped wedge cluster randomized trial in Kenya 2021 ·SHILAP Revista de lepidopterología ·Kenneth K. Mugwanya, Daniel Matemo, Caitlin W. Scoville, Kristin Beima‐Sofie, Allison Meisner, Dickens Onyango, (unknown), (unknown), Cole Grabow, Ruanne V. Barnabas, Bryan J. Weiner, Jared M. Baeten, John Kinuthia, (unknown)	6
6	Case-Only Analysis of Gene-Environment Interactions Using Polygenic Risk Scores 2019 ·American Journal of Epidemiology ·Allison Meisner, Prosenjit Kundu, Nilanjan Chatterjee	13
7	Development of biomarker combinations for postoperative acute kidney injury via Bayesian model selection in a multicenter cohort study 2018 ·Biomarker Research ·Allison Meisner, Kathleen F. Kerr, Heather Thiessen‐Philbrook, F. Perry Wilson, Amit X. Garg, Michael G. Shlipak, Peter A. Kavsak, Richard Whitlock, Steven G. Coca, Chirag R. Parikh	5
8	Using ordinal outcomes to construct and select biomarker combinations for single-level prediction 2018 ·SHILAP Revista de lepidopterología ·Allison Meisner, Chirag R. Parikh, Kathleen F. Kerr	4
9	Urinalysis findings and urinary kidney injury biomarker concentrations 2017 ·BMC Nephrology ·Girish N. Nadkarni, Steven G. Coca, Allison Meisner, Shanti Patel, Kathleen F. Kerr, Uptal D. Patel, Jay L. Koyner, Amit X. Garg, Heather Thiessen‐Philbrook, Charles L. Edelstein, Michael G. Shlipak, Joe M El-Khoury, Chirag R. Parikh	8
10	Validity of a Neurological Scoring System for Canine X-Linked Myotubular Myopathy 2015 ·PubMed ·Jessica M. Snyder, Allison Meisner, David L. Mack, Melissa Goddard, (unknown), Robert W. Grange, Martin K. Childers	4
11	RiGoR: reporting guidelines to address common sources of bias in risk model development 2015 ·Biomarker Research ·Kathleen F. Kerr, Allison Meisner, Heather Thiessen‐Philbrook, Steven G. Coca, Chirag R. Parikh	17
12	Developing Risk Prediction Models for Kidney Injury and Assessing Incremental Value for Novel Biomarkers 2014 ·Clinical Journal of the American Society of Nephrology ·Kathleen F. Kerr, Allison Meisner, Heather Thiessen‐Philbrook, Steven G. Coca, Chirag R. Parikh	22
13	A Single Nucleotide Polymorphism in Inflammatory Gene RNASEL Predicts Outcome after Radiation Therapy for Localized Prostate Cancer 2013 ·Clinical Cancer Research ·Jonathan D. Schoenfeld, Danielle N. Margalit, Julie L. Kasperzyk, Irene M. Shui, Jennifer R. Rider, Mara M. Epstein, Allison Meisner, Stacey A. Kenfield, Neil E. Martin, Paul L. Nguyen, Philip W. Kantoff, Edward L. Giovannucci, Meir J. Stampfer, Lorelei A. Mucci	14
14	Modification of the Association Between Obesity and Lethal Prostate Cancer by TMPRSS2:ERG 2013 ·JNCI Journal of the National Cancer Institute ·Andreas Pettersson, Rosina T. Lis, Allison Meisner, Richard Flavin, Edward C. Stack, Michelangelo Fiorentino, Stephen P. Finn, Rebecca E. Graff, Kathryn L. Penney, Jennifer R. Rider, Elizabeth Nuttall, Neil E. Martin, Howard D. Sesso, Michaël Pollak, Meir J. Stampfer, Philip W. Kantoff, Edward L. Giovannucci, Massimo Loda, Lorelei A. Mucci	66
15	l -Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials 2012 ·American Journal of Psychiatry ·George I. Papakostas, Richard C. Shelton, John Zajecka, Bijan Etemad, Karl Rickels, Alisabet Clain, Lee Baer, Elizabeth D. Dalton, (unknown), David Schoenfeld, Michael Pencina, Allison Meisner, Teodoro Bottiglieri, Erik Nelson, David Mischoulon, Jonathan E. Alpert, James G. Barbee, Sidney Zisook, Maurizio Fava	182
16	CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3+ regulatory T cells with respect to lethal prostate cancer 2012 ·Modern Pathology ·Sabina Davidsson, (unknown), Swen‐Olof Andersson, Katja Fall, Allison Meisner, Michelangelo Fiorentino, Ove Andrén, Jennifer R. Rider	83
17	A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder 2012 ·The Journal of Clinical Psychiatry ·George I. Papakostas, Ottavio V. Vitolo, Waguih William IsHak, Mark Hyman Rapaport, John Zajecka, Gustavo Kinrys, David Mischoulon, (unknown), Katherine A. Hails, (unknown), (unknown), Allison Meisner, David Schoenfeld, Richard C. Shelton, Andrew Winokur, (unknown), Mohammed Abdul Bari, Maurizio Fava	22
18	Abstract 13709: Incident Congestive Heart Failure and Common Carotid Artery Diameter: The Framingham Offspring Study 2011 ·Circulation ·Joseph F. Polak, Allison Meisner, Michael Pencina, Ramachandran S. Vasan, Philip A. Wolf, Ralph B. D’Agostino	1
19	Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome 2011 ·European Heart Journal ·Christian Widera, Michael Pencina, Allison Meisner, Tibor Kempf, Kerstin Bethmann, (unknown), Hugo A. Katus, Evangelos Giannitsis, Kai C. Wollert	84
20	Associations of Carotid Artery Intima-Media Thickness (IMT) With Risk Factors and Prevalent Cardiovascular Disease 2010 ·Journal of Ultrasound in Medicine ·Joseph F. Polak, Michael Pencina, Allison Meisner, Karol M. Pencina, Lisa Brown, Philip A. Wolf, Ralph B. D’Agostino	116

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact